Through functionally mimicking VGLL4 and subsequently blocking YAP activity, this peptide potently suppresses gastric cancer growth in vitro and in mouse models, including nude mice bearing gastric cancer cells and H. pylori-infected mice [162]. Here, VGLL4 is linked to gastric cancer.